Parkinson's disease (PD) is a disabling neurodegenerative disorder that is expected to affect as many as 1,000,000 Americans this year. Human and animals studies have shown that parkinsonism results from the degeneration of nigrostriatal dopaminergic neurons. Currently, treatment strategies for PD patients are limited. Gaining a better understanding of how striatal function is altered by the disease should broaden the range and efficacy of treatments. In the last funding period we focused on how dopamine and acetylcholine modulate the properties of voltage dependent ion channels in identified normosensitive striatal neurons. These studies have provided fundamental new insights into how these neuromodulators control the excitability of striatal neurons. Now, we are in a position to take the next step toward understanding the pathophysiology of PD - namely, how does the depletion of intrastriatal dopamine alter striatal function? Simply stated, our central goals are 1) to determine how DA depletion alters the regulation of voltage-dependent ion channels in striatal medium spiny neurons and 2) to determine how this adaptation alters their integrative, state-dependent behavior. To this end, we will determine how DA depletion alters Na+ and Ca2+ currents and their modulation by D2 (Specific Aim 1) and D1 receptor activation (Specific Aim 2) in identified striatal neurons. These experiments will rely upon voltage-clamp and single cell reverse transcription-polymerase chain reaction (scRT-PCR) approaches in acutely isolated striatal neurons - techniques with which we have an established track record. The proposed studies will employ newly developed mouse transgenic models in which striatal dopamine levels are profoundly reduced, mimicking the state found in advanced PD. Adaptations in the signal transduction pathways linking receptors to channels will be characterized using a combination of pharmacological, molecular and transgenic strategies. Inferences drawn from this work about adaptations in the mechanisms governing state transitions and repetitive spike activity will be explicitly tested using current- and voltage-clamp techniques in a novel corticostriatal slice preparation where medium spiny neurons exhibit state-dependent behavior resembling that seen in vivo (Specific Aim 3).

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37NS034696-12
Application #
7060395
Study Section
Special Emphasis Panel (ZRG1-MDCN-4 (01))
Program Officer
Sutherland, Margaret L
Project Start
1996-02-01
Project End
2008-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
12
Fiscal Year
2006
Total Cost
$335,337
Indirect Cost
Name
Northwestern University at Chicago
Department
Physiology
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Zhai, Shenyu; Tanimura, Asami; Graves, Steven M et al. (2018) Striatal synapses, circuits, and Parkinson's disease. Curr Opin Neurobiol 48:9-16
Agarwal, Hitesh K; Zhai, Shenyu; Surmeier, D James et al. (2017) Intracellular Uncaging of cGMP with Blue Light. ACS Chem Neurosci 8:2139-2144
Sebel, Luke E; Graves, Steven M; Chan, C Savio et al. (2017) Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits. Neuropsychopharmacology 42:963-973
Ceglia, Ilaria; Lee, Ko-Woon; Cahill, Michael E et al. (2017) WAVE1 in neurons expressing the D1 dopamine receptor regulates cellular and behavioral actions of cocaine. Proc Natl Acad Sci U S A 114:1395-1400
Ren, Wenjie; Centeno, Maria Virginia; Berger, Sara et al. (2016) The indirect pathway of the nucleus accumbens shell amplifies neuropathic pain. Nat Neurosci 19:220-2
Shen, Weixing; Plotkin, Joshua L; Francardo, Veronica et al. (2015) M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia. Neuron 88:762-73
Rafalovich, Igor V; Melendez, Alexandria E; Plotkin, Joshua L et al. (2015) Interneuronal Nitric Oxide Signaling Mediates Post-synaptic Long-Term Depression of Striatal Glutamatergic Synapses. Cell Rep 13:1336-1342
Plotkin, Joshua L; Surmeier, D James (2015) Corticostriatal synaptic adaptations in Huntington's disease. Curr Opin Neurobiol 33:53-62
Surmeier, D James; Graves, Steven M; Shen, Weixing (2014) Dopaminergic modulation of striatal networks in health and Parkinson's disease. Curr Opin Neurobiol 29:109-17
Sagi, Yotam; Heiman, Myriam; Peterson, Jayms D et al. (2014) Nitric oxide regulates synaptic transmission between spiny projection neurons. Proc Natl Acad Sci U S A 111:17636-41

Showing the most recent 10 out of 68 publications